Literature DB >> 3294300

Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.

T E Peto1, R Bull, P R Millard, D W Mackenzie, C K Campbell, M E Haines, R G Mitchell.   

Abstract

Systemic mycosis due to Penicillium marneffei is described in a man infected with human immunodeficiency virus and who had travelled in S.W. China. He responded completely to treatment with amphotericin B and a prolonged course of ketoconazole. Problems of diagnosis are discussed and all previously reported cases reviewed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3294300     DOI： 10.1016/s0163-4453(88)97700-6

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


  12 in total

1.  Unusual cause of fever and diarrhea in a patient with AIDS. Penicillium marneffei infection.

Authors:  R Leung; J Y Sung; J Chow; C K Lai
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 2.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

3.  Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene.

Authors:  Nongnuch Vanittanakom; Pramote Vanittanakom; Roderick J Hay
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Restriction endonuclease analysis of Penicillium marneffei.

Authors:  N Vanittanakom; C R Cooper; S Chariyalertsak; S Youngchim; K E Nelson; T Sirisanthana
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

5.  Massive hepatosplenomegaly caused by Penicillium marneffei associated with human immunodeficiency virus infection in a Thai patient.

Authors:  A C Bateman; G R Jones; S O'Connell; F J Clark; M Plummeridge
Journal:  J Clin Pathol       Date:  2002-02       Impact factor: 3.411

6.  Development of an in vitro macrophage system to assess Penicillium marneffei growth and susceptibility to nitric oxide.

Authors:  M Cogliati; A Roverselli; J R Boelaert; D Taramelli; L Lombardi; M A Viviani
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

7.  Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

Authors:  M A Viviani; A M Tortorano; G Rizzardini; T Quirino; L Kaufman; A A Padhye; L Ajello
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

8.  In vitro sensitivity of Penicillium marneffei and Pythium insidiosum to various antifungal agents.

Authors:  A S Sekhon; A A Padhye; A K Garg
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens.

Authors:  K Supparatpinyo; K E Nelson; W G Merz; B J Breslin; C R Cooper; C Kamwan; T Sirisanthana
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

10.  Fatal necrotizing esophagitis due to Penicillium chrysogenum in a patient with acquired immunodeficiency syndrome.

Authors:  M Hoffman; E Bash; S A Berger; M Burke; I Yust
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.